Neuroscience Software Revenue and Competitors

Our goal is to provide a technical solution that will help psychiatrists understand the EEG reports and help diagnose, treat, and control the treatment outcome of a patient’s depression, thereby facilitating the work of clinicians and lowering the risk of patients’ death by suicide. Our software will work with most of the known clinical EEG devices. According to the number of channels of the EEG device, our AI platform analyzes available data from your device and checks for different biomarkers. The software will produce a report with a list of all identified biomarkers, based on both linear and nonlinear signal analysis, rated according to current patient condition and their probability of depression, from 1 to 10 (low probability to high). Additionally, our model will calculate the Depression Diagnosis Index (DDI) based on all provided information and all identified biomarkers.